SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Focused Visit (Follow-up) — Hippocrates

PatientHippocrates
Date of birth1937-01-10
IdentifiersMRN HR-AC005-SYN; SSN (made up) 000-05-8153
Document date2026-04-27
AuthorEleni Vasquez-Okafor, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Eight-week review. [S]

History of Present Illness

Hippocrates has been to physical therapy every week and does his strength and balance exercises most days. The therapist visited his house three weeks ago; a second rail has been fitted on the stairs and night lights in the hall. He wears shoes with a back indoors. His knee pain on stairs is 3 of 10 with the gel most mornings, and he takes acetaminophen a few times a week. He had a cold two weeks ago that has cleared; he did not take the nighttime cold remedy again. He sleeps six to six and a half hours without a sleep aid. He has had no falls. He had a DXA scan this morning. [S]

ElementDetail
Knee pain3 of 10 on stairs
DXAFemoral neck T-score -1.7; total hip -1.4; spine -0.6
FRAXMajor osteoporotic fracture 11 percent; hip 2.6 percent
FallsNone
ColdResolved

Review of Systems

SystemResultFinding
MusculoskeletalPositiveKnee ache on the hill; less on stairs
RespiratoryNegativeCough gone
IntegumentaryNegativeNo rash where he applies the gel
PsychiatricNegativeMood good; sleeping without a sleep aid

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Naproxen sodium 220 mg oral tablet, one or two tablets most days for knee pain, bought over the counter, for about two years; stopped at intake (Beers 2023: avoid chronic use)One or two tablets by mouth up to twice a day, self-directedOral route2024-03-01 to 2026-03-02stoppedS
Diphenhydramine 25 mg oral capsule at bedtime three or four nights a week for sleep, bought over the counter; stopped at intake (Beers 2023: strongly anticholinergic)One capsule at bedtime as needed, self-directedOral route2025-09-01 to 2026-03-02stoppedS
Acetaminophen 500 mg oral tablet, one or two tablets up to three times a day as needed for knee pain, no more than 3,000 mg in a dayOne to two tablets by mouth every eight hours as needed; no more than six tablets a dayOral route2026-03-02activeS
Vitamin D3 (cholecalciferol) 25 micrograms (1,000 units) oral tablet once dailyOne tablet by mouth dailyOral route2026-03-02activeS
Diclofenac 1% gel, 4 g rubbed into each painful knee up to four times a dayApply 4 g to each painful knee up to four times a dayTopical route2026-03-16activeS
Sodium chloride 0.65% nasal spray, two sprays in each nostril as needed for congestionTwo sprays in each nostril up to every four hours as neededNasal route2026-04-13 to 2026-04-23completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-04-27Body height168cmS
2026-04-27Body weight64.4kgS
2026-04-27Body mass index (BMI) [Ratio]22.8kg/m2S
2026-04-27Systolic blood pressure134mm[Hg]S
2026-04-27Diastolic blood pressure72mm[Hg]S
2026-04-27Heart rate66/minS
2026-04-27Respiratory rate16/minS
2026-04-27Body temperature36.4CelS
2026-04-27Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-04-27DXA Femur [T-score] Bone density-1.7{T-score}-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass; -2.5 or lower is osteoporosisLowS
2026-04-27DXA Hip [T-score] Bone density-1.4{T-score}-1.0 or higher is normal; between -1.0 and -2.5 is low bone mass; -2.5 or lower is osteoporosisLowS
2026-04-27DXA Lumbar spine [T-score] Bone density-0.6{T-score}May read falsely high with spinal osteoarthritisNormalS
2026-04-27Major osteoporotic fracture 10-year probability [Likelihood] Fracture Risk Assessment11%S
2026-04-27Hip fracture 10-year probability [Likelihood] Fracture Risk Assessment2.6%S
2026-04-27Pain severity - 0-10 verbal numeric rating [Score] - Reported3{score}S

Physical Exam

Vital signs recorded on 2026-04-27; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 134/72, pulse 66; weight 64.4 kg; height 168 cm, unchanged
MusculoskeletalBoth knees: crepitus, no effusion; quadriceps 4+ of 5
SkinNo irritation over the knees

Problems

ProblemClinical statusVerificationCodeProvenance
Slower walking, knee pain on stairs and one near-fall in the past six months, found on the comprehensive geriatric assessment at intake: gait speed 0.78 m/s, Timed Up and Go 13.8 seconds, unable to hold a tandem stance for 10 seconds, grip 24 kg; cause under evaluation with a geriatric medicine consultationresolvedconfirmed R26.81S — Synthetic presenting problem of normal aging found on a comprehensive geriatric assessment; superseded at the consultation, when knee osteoarthritis with reduced leg strength and balance was diagnosed.
Primary osteoarthritis of both knees, diagnosed clinically by the ACR criteria (knee pain, age over 50, morning stiffness under 30 minutes, crepitus, bony enlargement, no warmth), with reduced quadriceps strength and balance and an increased risk of falls; KOOS JR 62activeconfirmed M17.0S — Synthetic modern diagnosis made at the consultation: a common, mild condition of aging chosen for a figure with no documented illness; not a claim about his real knees.
Potentially inappropriate over-the-counter medicines (Beers 2023): naproxen most days for about two years and diphenhydramine for sleep three or four nights a week; both stopped at intakeresolvedconfirmed Z79.1S — Synthetic medication history found on the deprescribing review.
Low bone mass (femoral neck T-score -1.7, total hip -1.4) with vitamin D insufficiency (24 ng/mL); FRAX 10-year risk 11 percent major and 2.6 percent hip, below treatment thresholdsactiveconfirmed M85.89S — Synthetic DXA finding at eight weeks; not a claim about his real bones.
Common cold (viral upper respiratory infection) with runny nose, sore throat and a mild cough, no fever, chest clear, oxygen saturation 97 percent; COVID-19 and influenza tests negative; resolved in about ten daysresolvedconfirmed J06.9S — Synthetic acute illness; not a historical claim.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
SurveyKnee pain (0 to 10)Every visitCompleted today3 of 10 on stairs
SurveyKnee function (KOOS JR)Every visitDeferredKOOS JR was not given at this visit: the form was left out of the visit packet. No harm is likely: the pain score and examination were recorded today and both show improvement. Corrective action: KOOS JR added to the visit template for his osteoarthritis visits and booked for the four-month review
ExaminationKnee examination (range of movement, effusion, alignment, crepitus)Every visitCompleted todayCrepitus, no effusion; quadriceps 4+ of 5
Self-managementExercise and self-management (strength and balance program, tai chi)Every visitCompleted todayWeekly physical therapy and exercises most days
Self-managementHome safety checkOnce, after a fall or near-fallCompleted todayDone three weeks ago: second stair rail and night lights fitted
ExaminationGait speed, Timed Up and Go, 30-second chair stand and four-stage balance testAt intake and after a strength and balance programDueAfter the twelve-week program, at the four-month review
Medication safetyMedication review (Beers 2023): no NSAID tablets, sedating antihistamines or other anticholinergic medicines; over-the-counter purchasesEvery visitCompleted todayNo NSAID tablets or sleep aids; the nighttime cold remedy was not taken again
Medication safetyTopical diclofenac: skin and useEvery visitCompleted todayMost mornings; no skin irritation
LaboratoryALT with regular acetaminophen near 3 g a dayWith regular use near 3 g a dayNot indicatedA few doses a week
ImagingDXA and FRAXAt assessment, then every two years if untreatedCompleted todayFemoral neck -1.7, total hip -1.4, spine -0.6; FRAX 11 and 2.6 percent; no vertebral fracture
ExaminationStanding heightYearlyCompleted today168 cm, unchanged
Laboratory25-hydroxyvitamin DAt baseline, after repletion, then yearlyUp to dateRecheck at four months
Self-managementVaccination reviewYearlyCompleted todayPCV20 today; RSV and recombinant zoster at the wellness visit
SurveyWhat matters most (4Ms)Every visitCompleted todayWalking to his teaching again, stopping twice on the hill
SurveyMentation: mood, memory and sleep (4Ms)Every visitCompleted todayMood good; sleeping without a sleep aid

Goal progress:

Immunizations given today: Pneumococcal conjugate vaccine (PCV20), single dose, one or more years after PPSV23 at 65 [S]

Guideline basis: Age-Friendly Health Systems: the 4Ms (What Matters, Medication, Mentation, Mobility) (2026); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023); Updating STEADI for Primary Care: Recommendations From the American Geriatrics Society Workgroup (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); The clinician's guide to prevention and treatment of osteoporosis (2022); Osteoporosis in men: an Endocrine Society clinical practice guideline (2012); CMID: Clinical Monitoring Intelligence Database, rheumatoid arthritis and osteoarthritis, and osteoporosis monographs (2026)

Follow-up: Annual wellness visit in six weeks. Four-month review with repeat gait, balance and strength measures, vitamin D and KOOS JR. Next scheduled visit 2026-06-08: subsequent annual wellness visit. [S]